Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes Lower-extremity amputation (LEA) is a major […]
Blog
NR, Metabolism & Inflammation meeting @ IMMEDIAB
On the 27th of November the IMMEDIAB Lab is organising a themed meeting on Nuclear Receptors, Metabolism and Inflammation, all […]
F. Fumeron publishes in Mol Metab
New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans The […]
We’re Recruiting!
The IMMEDIAB Lab is recruiting a new postdoc, find the deets below!
WCI Sydney 2019
This week the IMMEDIAB Lab attended the 14th World Congres on Inflammation (WCI) at Sydney, Australia. The event ran from the 15th […]
S. Girardot publishes in Diabetes Technol Ther
Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy Continuous subcutaneous insulin infusion is one of the best ways to […]
FEBS Advanced Course 2019
On the 25th of August The IMMEDIAB lab attended this years’ FEBS Advanced Course in Epigenetics, Nuclear Receptors and Disease […]
IMMEDIAB retreat 2019
On the 19th of June, the entire Immediab team hopped on a train at Gare de Lyon, for the team’s […]
F. Fumeron publishes in Diabetes & Metabolism
Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort Type 2 diabetes is a multifactorial […]
Congratulations to our 2019 Interns
This year, the Immediab crew expanded as the lab welcomed three Master’s students for their research internship – Diane, Judith […]
